Jan 13, 2025With Enfusion, we are taking a bold step forward, uniting two innovative platforms that will redefine investment management, deliver meaningful efficiencies, and expand our global reach," said Jim Cox, CFO of Clearwater Analytics. Enfusion management expects preliminary full year 2024 revenue of approximately $201-202 million, representing 15 ...
Jan 13, 2025Investor Conference Call Scheduled for Today at 8:30 a.m. ET. BOISE, Idaho & CHICAGO, January 13, 2025--(BUSINESS WIRE)--Clearwater Analytics (NYSE: CWAN) ("Clearwater") and Enfusion, Inc. (NYSE ...
Jan 14, 2025愛達荷州博伊西和芝加哥, January 14, 2025--(美國商業資訊)--Clearwater Analytics (NYSE: CWAN) ("Clearwater")和Enfusion, Inc. (NYSE: ENFN) ("Enfusion")今天宣布達成最終合併協議。根據該協議,Clearwater將收購Enfusion,後者是投資管理和避險基金產業軟體即服務(SaaS)解決方案領域的領導者。收購價格為每股11.25美元,以大致 ...
Jan 13, 2025Clearwater Analytics has agreed to acquire Enfusion in a $1.5 billion cash-and-stock deal as the financial software maker looks to bolster its international presence and enter the hedge fund industry.
Jan 13, 2025Clearwater Analytics said it has entered into a definitive agreement to acquire investment management platform Enfusion for $1.5 billion. ... Enfusion reported preliminary ~15% year-over-year ...
Jan 14, 2025With Enfusion, we are taking a bold step forward, uniting two innovative platforms that will redefine investment management, deliver meaningful efficiencies, and expand our global reach," said Jim Cox, CFO of Clearwater Analytics. Enfusion management expects preliminary full year 2024 revenue of approximately $201-202 million, representing 15 ...
Jan 13, 2025Stay up-to-date with Enfusion news, including media alerts, news items and press releases. Enfusion. Menu. Platform; ... Clearwater Analytics to Acquire Enfusion for $1.5 Billion Expanding its Investment Management Platform with Front-to-Back Capabilities ... representing 15-16% year on year growth, and preliminary Annual Recurring Revenue (ARR ...
Jan 14, 2025Clearwater will pay about $760 million in cash and issue 23 to 28 million new shares to Enfusion shareholders as part of this process, and will also pay off Enfusion's $30 million tax receivable agreement. To finance the deal, the company has arranged an $800 million term loan B, alongside a $200 million revolving credit line.
Can’t find what you’re looking for?
Help us improve DuckDuckGo searches with your feedback